As in healthy individuals, there is a dose-dependency regarding the amount of glucose ingested, with greater incretin effects at higher doses, but at all glucose loads the incretin effect is significantly reduced in those with type 2 diabetes compared with healthy individuals (Fig. 6c,i) [3]. This evidence concerns the gene GCG and type 2 diabetes mellitus.